The First Fully AI-Designed Drug Reaches Phase 3 Trials—And Its Maker Is Already Profitable

The First Fully AI-Designed Drug Reaches Phase 3 Trials—And Its Maker Is Already Profitable | Health AI Central | Health AI Central